CENCORA ($COR) posted quarterly earnings results for Q1 2026 on Wednesday, February 4th. The company reported earnings of $4.08 per share, beating estimates of $4.07 by $0.01. The company also reported revenue of $85,932,020,000, missing estimates of $86,887,406,430 by $-955,386,430.
You can see Quiver Quantitative's $COR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CENCORA Insider Trading Activity
CENCORA insiders have traded $COR stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $COR stock by insiders over the last 6 months:
- STEVEN H COLLIS (Executive Chairman) has made 0 purchases and 2 sales selling 45,929 shares for an estimated $13,314,760.
- ROBERT P. MAUCH (President & CEO) has made 0 purchases and 6 sales selling 30,450 shares for an estimated $10,028,409.
- LAZARUS KRIKORIAN (SVP & Chief Accounting Officer) sold 4,031 shares for an estimated $1,383,580
- ELIZABETH S CAMPBELL (Executive Vice President) sold 3,351 shares for an estimated $1,146,377
- SILVANA BATTAGLIA (Executive Vice President) sold 1,677 shares for an estimated $578,565
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CENCORA Hedge Fund Activity
We have seen 687 institutional investors add shares of CENCORA stock to their portfolio, and 592 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,717,045 shares (+1157.8%) to their portfolio in Q3 2025, for an estimated $849,158,073
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,973,497 shares (+327.4%) to their portfolio in Q3 2025, for an estimated $616,777,017
- MARSHALL WACE, LLP added 1,672,762 shares (+518.9%) to their portfolio in Q3 2025, for an estimated $522,788,307
- TWO SIGMA ADVISERS, LP removed 1,368,400 shares (-94.7%) from their portfolio in Q3 2025, for an estimated $427,666,051
- BLACKROCK, INC. added 1,072,661 shares (+5.7%) to their portfolio in Q3 2025, for an estimated $335,238,742
- PACER ADVISORS, INC. removed 880,384 shares (-97.8%) from their portfolio in Q3 2025, for an estimated $275,146,411
- STATE STREET CORP added 782,911 shares (+9.3%) to their portfolio in Q3 2025, for an estimated $244,683,174
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CENCORA Government Contracts
We have seen $474,657 of award payments to $COR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PHARMACY ORDER WELIREG 40MG: $22,051
- PHARMACY ORDER BALVERSA 5MG TABLETS: $11,808
- PHARMACY ORDER BALVERSA 5MG TABLETS: $11,808
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
CENCORA Analyst Ratings
Wall Street analysts have issued reports on $COR in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 01/29/2026
- TD Cowen issued a "Buy" rating on 11/10/2025
- UBS issued a "Buy" rating on 11/07/2025
- Mizuho issued a "Outperform" rating on 11/06/2025
- Baird issued a "Outperform" rating on 11/06/2025
To track analyst ratings and price targets for CENCORA, check out Quiver Quantitative's $COR forecast page.
CENCORA Price Targets
Multiple analysts have issued price targets for $COR recently. We have seen 10 analysts offer price targets for $COR in the last 6 months, with a median target of $400.0.
Here are some recent targets:
- Erin Wright from Morgan Stanley set a target price of $400.0 on 01/29/2026
- Brian Tanquilut from Jefferies set a target price of $440.0 on 01/22/2026
- Michael Funk from B of A Securities set a target price of $360.0 on 01/05/2026
- Glen Santangelo from Barclays set a target price of $400.0 on 12/09/2025
- Lisa Gill from JP Morgan set a target price of $417.0 on 11/11/2025
- Stephen Baxter from Wells Fargo set a target price of $405.0 on 11/11/2025
- Charles Rhyee from TD Cowen set a target price of $400.0 on 11/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
